WHAT IS KNOWN:
Watchman device has emerged as an alternative treatment for the management of stroke risk in AF patients who cannot tolerate oral anti-coagulation. Randomized trials have demonstrated non-inferiority of the Watchman device in terms of both efficacy and safety when compared to coumadin.